Wissenschaftliche Arbeiten

Doç. Dr. Mehmet Orkun Sevik

57 Publikationen. Neben jeder Publikation steht die Quelle der Angabe.

Zurück zum Profil
  1. Resolution of cystoid macular edema with topical carbonic anhydrase inhibitor in a patient with retinal dystrophy associated with Cohen syndrome

    Ophthalmic Genetics, 2021

    DOI 10.1080/13816810.2021.1925928 PMID 33974487 2 Zitationen (Europe PMC) Quelle: ORCID

  2. The effect of COVID-19 pandemic restrictions on neovascular AMD patients treated with treat-and-extend protocol

    International Ophthalmology, 2021

    DOI 10.1007/s10792-021-01854-6 PMID 33864577 30 Zitationen (Europe PMC) Frei zugänglicher VolltextQuelle: ORCID

  3. 'Transcorneal Electrical Stimulation Therapy May Have A Stabilization Effect on Multifocal Electroretinography for Patients with Retinitis Pigmentosa'.

    Retina (Philadelphia, Pa.), 2021

    DOI 10.1097/iae.0000000000003386 PMID 34923514 6 Zitationen (Europe PMC) Frei zugänglicher VolltextQuelle: ORCID

  4. Clinical outcomes with a low add multifocal and an extended depth of focus intraocular lenses both implanted with mini-monovision.

    Eye (London, England), 2021

    DOI 10.1038/s41433-021-01600-3 PMID 34117383 16 Zitationen (Europe PMC) Frei zugänglicher VolltextQuelle: ORCID

  5. Immediate changes in blood pressure during intravitreal anti-VEGF agents' applications in exudative age-related macular degeneration patients

    International Ophthalmology, 2020

    DOI 10.1007/s10792-020-01431-3 PMID 32495059 3 Zitationen (Europe PMC) Quelle: ORCID

  6. Comparison of reading performance with low add bifocal and extended depth of focus intraocular lenses implanted with mini-monovision

    International Ophthalmology, 2020

    DOI 10.1007/s10792-020-01584-1 PMID 32914276 13 Zitationen (Europe PMC) Quelle: ORCID

  7. Topical Treatment of Persistent Epithelial Defects with a Matrix Regenerating Agent

    Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics, 2018

    DOI 10.1089/jop.2018.0025 PMID 30312119 7 Zitationen (Europe PMC) Frei zugänglicher VolltextQuelle: ORCID